UB-221 not only neutralizes free IgE but also down-regulates IgE synthesis which Xolair cannot achieve
LUB-221 neutralizes free IgE more effectively than Xolair® with a binding affinity 8-fold higher than that of Xolair®.
The serum half-life of UB-221 doubles that of Xolair® in monkey studies